Mohammed L. Abba

Ludolf Krehl Str. 6
Heidelberg, BW 68135, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Dose-Adjusted Treatment With 7-Day Venetoclax Plus Azacitidine or Decitabine in Patients With Acute Myeloid Leukaemia.

Dose-Adjusted Treatment With 7-Day Venetoclax Plus Azacitidine or Decitabine in Patients With Acute Myeloid Leukaemia.

Journal: European journal of haematology

Published: May 26, 2026

A randomized controlled clinical trial of intranasal versus subcutaneous midazolam for agitation in terminal illness (MinTU study).

A randomized controlled clinical trial of intranasal versus subcutaneous midazolam for agitation in terminal illness (MinTU study).

Journal: Palliative medicine

Published: March 23, 2026

Hemodynamic effects of red blood cell transfusion in patients with hemato-oncologic diseases.

Hemodynamic effects of red blood cell transfusion in patients with hemato-oncologic diseases.

Journal: Frontiers in medicine

Published: September 23, 2025

Primary CD34+ cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243.

Primary CD34+ cells of patients with vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome are highly sensitive to targeted treatment with TAK-243.

Journal: British journal of haematology

Published: June 17, 2025

Gilteritinib in an Isolated CNS Recurrence of FLT3-ITD Positive AML.

Gilteritinib in an Isolated CNS Recurrence of FLT3-ITD Positive AML.

Journal: Clinical case reports

Published: April 21, 2025

Understanding iron homeostasis in MDS: the role of erythroferrone.

Understanding iron homeostasis in MDS: the role of erythroferrone.

Journal: Frontiers in oncology

Published: March 21, 2024

The bispecific innate cell engager AFM28 eliminates CD123+ leukemic stem and progenitor cells in AML and MDS.

The bispecific innate cell engager AFM28 eliminates CD123+ leukemic stem and progenitor cells in AML and MDS.

Journal: Nature communications

Published: February 21, 2024

Changes in Methylation across Structural and MicroRNA Genes Relevant for Progression and Metastasis in Colorectal Cancer.

Changes in Methylation across Structural and MicroRNA Genes Relevant for Progression and Metastasis in Colorectal Cancer.

Journal: Cancers

Published: November 10, 2021

55/m-Fatigue and upper abdominal complaints : Preparation for the medical specialist examination: part 101

55/m-Fatigue and upper abdominal complaints : Preparation for the medical specialist examination: part 101

Journal: Der Internist

Published: August 19, 2021

Prognostic value of beta-blocker doses in patients with ventricular tachyarrhythmias.

Prognostic value of beta-blocker doses in patients with ventricular tachyarrhythmias.

Journal: Heart and vessels

Published: July 25, 2021

Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias.

Effect of Mineralocorticoid Receptor Antagonists on the Prognosis of Patients with Ventricular Tachyarrhythmias.

Journal: Pharmacology

Published: June 30, 2021

Metagenomic analysis of primary colorectal carcinomas and their metastases identifies potential microbial risk factors.

Metagenomic analysis of primary colorectal carcinomas and their metastases identifies potential microbial risk factors.

Journal: Molecular oncology

Published: May 24, 2021

Showing 1-12 of 38

Last Updated: 09/26/2026